Robert James Rudelius

Robert James Rudelius is a declared insider at 2 companies (board member); the most frequent names are PetVivo Holdings, Inc. and Axogen, Inc. We count 37 filings; the first trade dates from 8 September 2017 and the latest from 18 September 2026.

The open-market side counts 2 purchases for €5,258 alongside 1 sale for €243k. Sales outweigh purchases by €238k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 20 share grants and 5 option exercises.

The newest entry dates from 21 September 2026: a share grant of €1,254, in PetVivo Holdings, Inc. The latest purchase dates back some time: it was published 1,429 days ago, on 22 November 2022. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.